共 50 条
- [23] An Economic Analysis of Ferric Derisomaltose versus Ferric Carboxymaltose in the Treatment of Iron Deficiency Anemia in Patients with Inflammatory Bowel Disease in Norway, Sweden, and Finland CLINICOECONOMICS AND OUTCOMES RESEARCH, 2021, 13 : 9 - 18
- [28] Correction to: Intravenous ferric derisomaltose versus saccharated ferric oxide for iron deficiency anemia associated with menorrhagia: a randomized, open-label, active-controlled, noninferiority study International Journal of Hematology, 2022, 116 : 976 - 977
- [29] Intravenous ferric derisomaltose for iron-deficiency anemia associated with gastrointestinal diseases: a single-arm, randomized, uncontrolled, open-label study International Journal of Hematology, 2022, 116 : 846 - 855
- [30] Safety and Efficacy of Intravenous Ferric Derisomaltose Compared to Iron Sucrose for Iron Deficiency Anemia in Patients with Chronic Kidney Disease With and Without Heart Failure AMERICAN JOURNAL OF CARDIOLOGY, 2021, 152 : 138 - 145